CG MedTech Co.,Ltd. (KOSDAQ:056090)
987.00
-1.00 (-0.10%)
Feb 21, 2025, 9:00 AM KST
CG MedTech Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 20, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Market Capitalization | 101,917 | 93,078 | 93,078 | 45,362 | 35,921 | 42,184 | Upgrade
|
Market Cap Growth | 36.96% | 0% | 105.19% | 26.28% | -14.85% | -43.25% | Upgrade
|
Enterprise Value | 84,158 | 84,503 | 65,855 | 55,847 | 51,688 | 58,160 | Upgrade
|
Last Close Price | 987.00 | 1180.00 | 1180.00 | 985.00 | 894.00 | 1102.00 | Upgrade
|
PE Ratio | - | 57.14 | - | - | - | - | Upgrade
|
Forward PE | - | 26.54 | 26.54 | 26.54 | 26.54 | 26.54 | Upgrade
|
PS Ratio | 1.88 | 2.66 | 2.26 | 1.19 | 1.29 | 1.21 | Upgrade
|
PB Ratio | 1.32 | 1.55 | 1.61 | 1.58 | 1.33 | 1.11 | Upgrade
|
P/TBV Ratio | 1.93 | 1.58 | 1.65 | 1.69 | 1.40 | 1.16 | Upgrade
|
P/FCF Ratio | 112.54 | - | - | 120.94 | 18.47 | - | Upgrade
|
P/OCF Ratio | 50.06 | - | - | 36.66 | 16.71 | - | Upgrade
|
EV/Sales Ratio | 2.38 | 2.42 | 1.60 | 1.47 | 1.86 | 1.67 | Upgrade
|
EV/EBITDA Ratio | 21.51 | 20.83 | - | 41.45 | - | 52.86 | Upgrade
|
EV/EBIT Ratio | 38.00 | 38.34 | - | - | - | - | Upgrade
|
EV/FCF Ratio | 92.93 | - | - | 148.89 | 26.57 | - | Upgrade
|
Debt / Equity Ratio | 0.07 | 0.07 | 1.14 | 1.04 | 0.88 | 0.62 | Upgrade
|
Debt / EBITDA Ratio | 1.18 | 1.08 | - | 22.25 | - | 21.24 | Upgrade
|
Debt / FCF Ratio | 5.10 | - | - | 79.92 | 12.27 | - | Upgrade
|
Asset Turnover | 0.41 | 0.32 | 0.38 | 0.55 | 0.41 | 0.48 | Upgrade
|
Inventory Turnover | 1.60 | 1.55 | 2.16 | 2.32 | 1.81 | 1.46 | Upgrade
|
Quick Ratio | 3.69 | 2.42 | 1.14 | 1.22 | 0.68 | 1.53 | Upgrade
|
Current Ratio | 5.49 | 3.84 | 1.30 | 1.78 | 1.16 | 3.35 | Upgrade
|
Return on Equity (ROE) | -3.15% | 2.22% | -43.51% | -18.67% | -37.75% | -4.90% | Upgrade
|
Return on Assets (ROA) | 1.62% | 1.25% | -5.88% | -0.73% | -9.97% | -0.98% | Upgrade
|
Return on Capital (ROIC) | 1.98% | 1.47% | -6.97% | -0.93% | -12.03% | -1.12% | Upgrade
|
Return on Capital Employed (ROCE) | 2.71% | 3.13% | - | - | - | - | Upgrade
|
Earnings Yield | -1.76% | 1.75% | -19.92% | -10.96% | -34.19% | -4.48% | Upgrade
|
FCF Yield | 0.89% | -4.37% | -6.64% | 0.83% | 5.42% | -6.69% | Upgrade
|
Buyback Yield / Dilution | 20.09% | -18.55% | -49.47% | -16.01% | -0.40% | -0.45% | Upgrade
|
Total Shareholder Return | 20.09% | -18.55% | -49.47% | -16.01% | -0.40% | -0.45% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.